Unichem Laboratories Ltd.

NSE: UNICHEMLAB | BSE: 506690 | ISIN: INE351A01035 | Industry: Pharmaceuticals
| Mid-range Performer
599.0500 -2.35 (-0.39%)
NSE Jul 08, 2025 15:31 PM
Volume: 62,452
 

599.05
-0.39%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 13% YoY to | 344 crore (I-direct estimate: | 350 crore) on account of 18% growth in export sales to | 119 crore (I-direct estimate: | 125 crore). Domestic sales grew 7% YoY to | 187 crore (Idirect estimate: | 197 crore) EBITDA margins declined 30 bps YoY to 9.8% (I-direct estimate: 12.8%) mainly due to higher employee and other expenditure. EBITDA increased 9% YoY to | 34 crore (I-direct estimate: | 45 crore) Net profit increased 14% YoY to | 32 crore (I-direct estimate of | 34.2)....
Unichem Laboratories Ltd. is trading above its 50 day SMA of 594.7
More from Unichem Laboratories Ltd.
Recommended